Gaia Griguolo/X
Jun 1, 2025, 06:15
Gaia Griguolo: PROs from EMBER3 Trial Presented at ASCO25
Gaia Griguolo, Junior Faculty Fixed-term Researcher at University of Padua, posted on X:
“PROs from EMBER3 trial presented at ASCO25 by Giuseppe Curigliano.
QoL and global health status generally maintained with imlunestrant e imlunestrant+abema. However, significant more diarrhea reported with imlunestrant+abema.”
More posts featuring ASCO25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 2, 2025, 18:07
Jun 2, 2025, 18:00
Jun 2, 2025, 17:43
Jun 2, 2025, 17:18
Jun 2, 2025, 17:06
Jun 2, 2025, 15:40
Jun 2, 2025, 15:37
Jun 2, 2025, 15:20